In light of the current outbreak of the novel coronavirus disease, (known as COVID-19), we have consulted with medical experts on our Board of Directors…
In light of current developments with regard to COVID-19, the International Symposium on Malignant Mesothelioma previously scheduled for April 6 and 7 in San Antonio, Texas, will be rescheduled. This decision comes after careful deliberation and…
The Mesothelioma Applied Research Foundation is pleased to announce that Boris Sepesi, MD has joined its board of directors, the organization’s main governing board. Dr. Boris Sepesi is an associate professor in the department of thoracic and cardiovascular surgery at…
The Mesothelioma Applied Research Foundation knows that the information and the community support provided at our International Symposium on Malignant Mesothelioma — April 6-7 in…
The largest conference focusing on mesothelioma from a patient-perspective is a welcoming and supportive event for the entire mesothelioma community. Read below for more details…
The Department of Defense (DOD) Peer Reviewed Cancer Research Program (PRCRP) has received $110 million in Fiscal Year 2020 (FY20) from Congress – a $20 million increase from FY19…
The Mesothelioma Applied Research Foundation is honored to announce the 2020 recipients of the organization’s Pioneer Award, Hope-Builder Award and the Above and Beyond Award. The awards, which will be presented during the Awards Dinner…
The fourteenth annual Lung Leavin’ Day is next Saturday, Feb. 1 in St. Paul, MN. This Fundraise for Meso event is organized by Heather Von St James, a…





